Natural History of Severe Allergic Inflammation and Reactions
-
- STATUS
- Recruiting
-
- participants needed
- 2150
-
- sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
Summary
- Background
-
- Allergic inflammation is central to allergy-related diseases and disorders, such as asthma,
food allergies, and atopic dermatitis. Atopic dermatitis, commonly called eczema is a
chronic, noncontagious skin condition, usually starting in the first years of life, which
causes itching and scaling of an individual s skin. Because atopic dermatitis is a common
condition in children who have allergy-related diseases, including asthma, researchers are
interested in studying both individuals with atopic dermatitis and their close relatives
(parents and children) to better understand how allergy-related diseases develop and
progress. In addition, some patients with inherited disorders with features including atopic
dermatitis or other aspects of allergy such as food allergy, asthma, hay fever, hives, and
others, will also be seen.
- Objectives
- To study the natural history of diseases of allergic inflammation, such as atopic
dermatitis or genetic disorders associated with allergic inflammation.
- Eligibility
- Children and adolescents between 1 month and 21 years of age who have a documented history of moderate to severe atopic dermatitis.
- Individuals between 1 month and 80 years of age who have a suspected genetic or inherited allergy disorder related to atopic dermatitis or allergic pathways.
- Child and adult relatives of eligible participants will also be studied on this
protocol.
- Design
- The study will require one initial visit to the National Institutes of Health Clinical Center (lasting 1-5 days), as well as any required follow-up visits for treatment and research studies. Participants will receive treatment for atopic dermatitis and other allergic diseases as part of the study for up to 1 year.
- Participants will have some or all of the following tests as part of this study:
- A detailed physical examination and medical history
- Allergy skin prick testing to examine participants' responses to different allergens.
- Blood samples for additional allergen testing, testing the immune system, and other research purposes
- Skin punch biopsy to take a skin sample
- Lung function tests to measure airflow from the lungs and inflammation
- Food-related tests to diagnose potential food allergies
- Leukapheresis to collect white blood cells only
- Research samples, including stool specimens, saliva samples, buccal swabs (to collect cells from the inside of the cheek), and skin cell samples
- Clinical digital photography to provide images of affected and healthy skin.
- Participants will be asked to return for follow-up visits and tests for up to 1 year after the initial visit(s).
- Allergic inflammation is central to allergy-related diseases and disorders, such as asthma,
food allergies, and atopic dermatitis. Atopic dermatitis, commonly called eczema is a
chronic, noncontagious skin condition, usually starting in the first years of life, which
causes itching and scaling of an individual s skin. Because atopic dermatitis is a common
condition in children who have allergy-related diseases, including asthma, researchers are
interested in studying both individuals with atopic dermatitis and their close relatives
(parents and children) to better understand how allergy-related diseases develop and
progress. In addition, some patients with inherited disorders with features including atopic
dermatitis or other aspects of allergy such as food allergy, asthma, hay fever, hives, and
others, will also be seen.
Description
Allergic inflammation is central to the pathogenesis of allergic diseases, including atopic dermatitis, asthma, allergic rhinitis, and food allergy. These disorders are common, affecting up to 50 million Americans, and their pathophysiology remains poorly understood. Among allergic diseases, atopic dermatitis is common, with a prevalence of up to 20% in children. It is associated with the most dramatic elevations of IgE levels and most prominent T-helper type 2 cell (Th2) inflammation, and treatment remains challenging. Atopic dermatitis, eosinophilic inflammation, and systemic immediate hypersensitivity reactions are heralding manifestation of allergic disease in many children, making these ideal disorders for studying the effector mechanisms promoting the development and progression of allergic diseases. In addition to these manifestations, there are also a number of characterized genetic and congenital diseases, most presenting in childhood, that have prominent allergic manifestations, including dermatitis, or affect atopic pathways. These disorders provide further opportunity for advancing our understanding of the genetics and pathophysiology of diseases of allergic inflammation. The NIAID Laboratory of Allergic Diseases (LAD) has a long interest in exploring the mechanisms of allergic inflammation. Utilizing the resources of the LAD and the NIH Clinical Center, we will advance our understanding of allergic inflammation and the genetics and pathogenesis of allergic diseases through the study of these patients. The findings of this protocol will have implications for improved diagnosis, treatment and prevention of allergic diseases, including atopic asthma
Details
| Condition | PGM3 Deficiency, Eosinophilic and/or Atopic Dermatitis, OSMR Deficiency, Primary Localized Cutaneous Amyloidosis, Hereditary Alpha-tryptasemia |
|---|---|
| Clinical Study Identifier | NCT01164241 |
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
| Last Modified on | 25 October 2022 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer